Paul B. Chapman - Researcher Profile

Publications

2 shown

Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion

Ravid Straussman , Teppei Morikawa , Kevin Shee +16 more

2012 Nature 1710 citations

Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation

Paul B. Chapman , Axel Hauschild , Caroline Robert +25 more

Vemurafenib produced improved rates of overall and progression-free survival in patients with previously untreated melanoma with the BRAF V600E mutation. (Funded by Hoffmann-La ...

2011 New England Journal of Medicine 7590 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 9,300
Institution: Memorial Sloan Kettering Cancer Center

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0003-1618-0811

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.